RxDoctor Payments Data

Khalil Ibrahim, MD

Cardiovascular Disease · Chicago, ILNPI 1427324441

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $12,067 of the $19,644 with a category attached, or 61.4%. It is spread thinly across 24 manufacturers, the largest accounting for just 23.1%. Among cardiovascular disease clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,644in general payments, 2019–2025

Across 217 payments — averaging $90.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$5K
  • Edwards Lifesciences$4K
  • Abbott$3K
  • Medtronic$2K
  • Abiomed$1K
  • W. L. Gore & Associates, Inc.$900
  • plus $3K from 18 others

What the payments were for

  • Consulting fees$2,00010%
  • Travel & lodging$5,48528%
  • Food & beverage$12,06761%
  • Education$910%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,644 in reported general payments places this provider in the 90th percentile of 932 cardiovascular disease providers in Illinois.

See all cardiovascular disease providers in Illinois →

Medicare billing

Part B allowed, 2024
$66,922
Medicare patients
271
Services billed
594

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban37$33,832
JardianceEmpagliflozin16$16,622
Praluent PenAlirocumab19$8,498
Atorvastatin Calcium59$470
Carvedilol49$385
Metoprolol Succinate27$324
Nifedipine ErNifedipine11$255
Lisinopril36$251
Amlodipine Besylate34$200
Losartan Potassium16$172
ClopidogrelClopidogrel Bisulfate15$165
Chlorthalidone13$160
Spironolactone38$160
Furosemide46$155

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Chicago

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →